Corporate Banner
Satellite Banner
Technology Networks Header
Friday, November 28, 2014
 
Register | Sign in
Home Page>Products
  Product News
BioCision Announces Industry’s First Automated Biospecimen Thawing System
Wednesday, November 12, 2014
Intelligent device utilizes adaptive sensing technology for accurate and standardized thawing.

IDT Launches GMP MGB Eclipse® Probes for In Vitro Diagnostic Use
Tuesday, November 11, 2014
High quality, excellent service, and product transparency for human qPCR diagnostic applications.

Dolomite Launches Resealable Chip Interface
Monday, November 10, 2014
Resealable Chip Interface offers easy access to microfluidic chip surface.

Quest Diagnostics Introduces BRCAvantage Plus™
Friday, November 07, 2014
First major service extension to the company's BRCAvantage™ BRCA1 and BRCA2 mutation test menu offers screening for five new non-BRCA genes shown to increase risk of inherited breast cancer.

Merck Millipore's New SNAP i.d.® 2.0 System for Immunohistochemistry
Friday, November 07, 2014
Offers parallel processing of up to 24 slides at once, without the cost of automation.

Top Ten Pharma Uses Time Saving Fill-it System in Biologics Manufacturing
Friday, November 07, 2014
To assure consistent quality cell banks and reference standards at half the cost.

EKF Molecular to Exhibit at AMP 2014
Friday, November 07, 2014
Senior executives on hand to discuss collaborative research with MGH aimed at developing routine blood based tests for cancer.

Merck Millipore's Guava easyCyte™ 12 Flow Cytometer
Friday, November 07, 2014
Increased performance provides better sensitivity and resolution.

Simple and Reliable Determination of Acesulfame in Vinegar
Friday, November 07, 2014
Detection of acesulfame using the Thermo Scientific™ Acclaim™ Mixed-Mode WAX-1 column.

<< 3 4 5 6 7 8 9 >>
Showing Results 51 - 60 of 10688
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv